| Patent | Date |
|---|
Anti-alphabetatcr Antibody
App 20220153841 - Snell; Daniel ; et al. | 2022-05-19 |
scFv-Fc dimers that bind transforming growth factor-.beta.1 with high affinity, avidity and specificity
Grant 11,325,971 - Qiu , et al. May 10, 2 | 2022-05-10 |
Site-specific Glycoengineering Of Targeting Moieties
App 20220119547 - AVILA; Luis ; et al. | 2022-04-21 |
Site-specific Antibody-drug Conjugation Through Glycoengineering
App 20220089763 - Pan; Clark ; et al. | 2022-03-24 |
Anti-.alpha..beta.TCR antibody
Grant 11,186,638 - Snell , et al. November 30, 2 | 2021-11-30 |
Site-specific antibody-drug conjugation through glycoengineering
Grant 11,130,816 - Pan , et al. September 28, 2 | 2021-09-28 |
Glp-2 Analogs And Peptibodies For Administration Before, During Or After Surgery
App 20210169986 - PAN; Clark ; et al. | 2021-06-10 |
Fc Containing Polypeptides With Altered Glycosylation And Reduced Effector Function
App 20210147524 - PAN; Clark ; et al. | 2021-05-20 |
Site-specific glycoengineering of targeting moieties
Grant 10,995,148 - Avila , et al. May 4, 2 | 2021-05-04 |
Affinity Purification Of Glycoside-cleaving Enzymes
App 20210040465 - Dwyer; Brian ; et al. | 2021-02-11 |
Fc containing polypeptides with altered glycosylation and reduced effector function
Grant 10,836,813 - Pan , et al. November 17, 2 | 2020-11-17 |
Parathyroid Hormone Variants
App 20200247865 - Kind Code | 2020-08-06 |
Recombinant Follistatin-fc Fusion Proteins And Use In Treating Duchenne Muscular Dystrophy
App 20200247856 - Kind Code | 2020-08-06 |
Engineered anti-TGF-.beta. antibodies and antigen-binding fragments
Grant 10,730,936 - Wei , et al. | 2020-08-04 |
Glp-2 Fusion Polypeptides And Uses For Treating And Preventing Gastrointestinal Conditions
App 20200199192 - PAN; Clark ; et al. | 2020-06-25 |
Hyperglycosylated Binding Polypeptides
App 20200140564 - PAN; Clark ; et al. | 2020-05-07 |
Scfv-fc Dimers That Bind Transforming Growth Factor-beta1 With High Affinity, Avidity And Specificity
App 20200131258 - Qiu; Huawei ; et al. | 2020-04-30 |
ScFv-Fc dimers that bind transforming growth factor-BETA1 with high affinity, avidity and specificity
Grant 10,508,146 - Qiu , et al. Dec | 2019-12-17 |
Hyperglycosylated binding polypeptides
Grant 10,494,439 - Pan , et al. De | 2019-12-03 |
Site-specific Antibody-drug Conjugation Through Glycoengineering
App 20190233531 - Pan; Clark ; et al. | 2019-08-01 |
Nucleotide sequences encoding VEGF antagonist compositions of FLT-1 and uses thereof
Grant 10,308,917 - Stefano , et al. | 2019-06-04 |
Site-specific antibody-drug conjugation through glycoengineering
Grant 10,214,589 - Pan , et al. Feb | 2019-02-26 |
Recombinant Follistatin-FC Fusion Proteins and Use in Treating Duchenne Muscular Dystrophy
App 20180362604 - Rong; Haojing ; et al. | 2018-12-20 |
Conjugated C1 Esterase Inhibitor and Uses Thereof
App 20180333473 - Holmes; Kevin ; et al. | 2018-11-22 |
Thyroid Stimulating Hormone Compositions
App 20180326082 - PAN; Clark ; et al. | 2018-11-15 |
Anti-alphabetatcr Antibody
App 20180237522 - Snell; Daniel ; et al. | 2018-08-23 |
Scfv-fc Dimers That Bind Transforming Growth Factor-beta1 With High Affinity, Avidity And Specificity
App 20180222970 - Qiu; Huawei ; et al. | 2018-08-09 |
Anti-.alpha..beta.TCR antibody
Grant 10,017,573 - Snell , et al. July 10, 2 | 2018-07-10 |
Fc Containing Polypeptides With Altered Glycosylation And Reduced Effector Function
App 20180100010 - PAN; Clark ; et al. | 2018-04-12 |
Hyperglycosylated Binding Polypeptides
App 20170369584 - PAN; Clark ; et al. | 2017-12-28 |
Conjugated C1 Esterase Inhibitor and Uses Thereof
App 20170360905 - Holmes; Kevin ; et al. | 2017-12-21 |
Engineered Anti-tgf-beta Antibodies And Antigen-binding Fragments
App 20170342144 - Wei; Ronnie ; et al. | 2017-11-30 |
Fc containing polypeptides with altered glycosylation and reduced effector function
Grant 9,790,268 - Pan , et al. October 17, 2 | 2017-10-17 |
Engineered anti-TGF-beta antibodies and antigen-binding fragments
Grant 9,783,604 - Wei , et al. October 10, 2 | 2017-10-10 |
Site-specific Antibody-drug Conjugation Through Glycoengineering
App 20170267774 - Pan; Clark ; et al. | 2017-09-21 |
Hyperglycosylated binding polypeptides
Grant 9,701,753 - Pan , et al. July 11, 2 | 2017-07-11 |
Fc Containing Polypeptides With Altered Glycosylation And Reduced Effector Function
App 20170107276 - PAN; Clark ; et al. | 2017-04-20 |
Thyroid Stimulating Hormone Compositions
App 20170065725 - PAN; Clark ; et al. | 2017-03-09 |
Site-specific antibody-drug conjugation through glycoengineering
Grant 9,580,511 - Pan , et al. February 28, 2 | 2017-02-28 |
Vegf Antagonist Compositions And Uses Thereof
App 20160326501 - Stefano; James ; et al. | 2016-11-10 |
VEGF antagonist compositions and uses thereof
Grant 9,441,029 - Stefano , et al. September 13, 2 | 2016-09-13 |
C1 Inhibitor Fusion Proteins and Uses Thereof
App 20160130324 - Norton; Angela ; et al. | 2016-05-12 |
Site-specific Glycoengineering Of Targeting Moieties
App 20160060354 - AVILA; Luis ; et al. | 2016-03-03 |
Engineered Anti-tgf-beta Antibodies And Antigen-binding Fragments
App 20160017026 - WEI; Ronnie ; et al. | 2016-01-21 |
Anti Alphabetatcr Antibody
App 20150099861 - Snell; Daniel ; et al. | 2015-04-09 |
Hyperglycosylated Binding Polypeptides
App 20150079070 - PAN; Clark ; et al. | 2015-03-19 |
Thyroid Stimulating Hormone Compositions
App 20140357846 - PAN; Clark ; et al. | 2014-12-04 |
Site-specific Antibody-drug Conjugation Through Glycoengineering
App 20140294867 - PAN; Clark ; et al. | 2014-10-02 |
Fc Containing Polypeptides With Altered Glycosylation And Reduced Effector Function
App 20140271676 - PAN; Clark ; et al. | 2014-09-18 |
Human TIMP-1 Antibodies
App 20140086935 - Pan; Clark ; et al. | 2014-03-27 |
Vegf Antagonist Compositions And Uses Thereof
App 20130324465 - Stefano; James ; et al. | 2013-12-05 |
Human Timp-1 Antibodies
App 20130302340 - Pan; Clark ; et al. | 2013-11-14 |
Human Timp-1 Antibodies
App 20110262429 - PAN; CLARK ; et al. | 2011-10-27 |
Human TIMP-1 antibodies
Grant 7,993,849 - Pan , et al. August 9, 2 | 2011-08-09 |
Modified Il-4 Mutein Receptor Antagonists
App 20110183920 - Pan; Clark ; et al. | 2011-07-28 |
Modified IL-4 mutein receptor antagonists
Grant 7,785,580 - Pan , et al. August 31, 2 | 2010-08-31 |
Pituitary adenylate cyclase activating peptide (PACAP) receptor (VPAC2) agonists and their pharmacological methods of use
App 20090258826 - Froland; Wayne A. ; et al. | 2009-10-15 |
Pituitary adenylate cyclase activating peptide (PACAP) receptor 3 (R3) agonists and their pharmacological methods of use
Grant 7,507,714 - Pan , et al. March 24, 2 | 2009-03-24 |
Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use
Grant 7,494,978 - Pan , et al. February 24, 2 | 2009-02-24 |
Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use
Grant 7,488,716 - Pan , et al. February 10, 2 | 2009-02-10 |
Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use
Grant 7,488,715 - Pan , et al. February 10, 2 | 2009-02-10 |
Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use
Grant 7,488,714 - Pan , et al. February 10, 2 | 2009-02-10 |
Human TIMP-1 Antibodies
App 20090017037 - Pan; Clark ; et al. | 2009-01-15 |
Modified Il-4 Mutein Receptor Antagonists
App 20090010874 - Pan; Clark ; et al. | 2009-01-08 |
Pegylation of Vasoactive Intestinal Peptide (Vip) / Pituitary Adenylate Cyclase Activating Peptide (Pacap) Receptor 2 (Vpac2) Agonists and Methods of Use
App 20080261863 - Whelan; James ; et al. | 2008-10-23 |
Human TIMP-1 antibodies
Grant 7,432,364 - Pan , et al. October 7, 2 | 2008-10-07 |
Modified IL-4 mutein receptor antagonists
Grant 7,404,957 - Pan , et al. July 29, 2 | 2008-07-29 |
Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use
Grant 7,399,745 - Pan , et al. July 15, 2 | 2008-07-15 |
Pituitary adenylate cyclase activating peptide (PACAP) receptor (VPAC2) agonist peptide
Grant 7,378,494 - Froland , et al. May 27, 2 | 2008-05-27 |
Human TIMP-1 antibodies
App 20070160614 - Pan; Clark ; et al. | 2007-07-12 |
Human TIMP-1 antibodies
Grant 7,091,323 - Pan , et al. August 15, 2 | 2006-08-15 |
Methods of treating type 2 diabetes with peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists
Grant 7,041,646 - Pan , et al. May 9, 2 | 2006-05-09 |
Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use
App 20060003934 - Pan; Clark ; et al. | 2006-01-05 |
Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use
App 20060003935 - Pan; Clark ; et al. | 2006-01-05 |
Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use
App 20060003417 - Pan; Clark ; et al. | 2006-01-05 |
Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use
App 20060003418 - Pan; Clark ; et al. | 2006-01-05 |
Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use
App 20060003419 - Pan; Clark ; et al. | 2006-01-05 |
Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use
App 20050288248 - Pan, Clark ; et al. | 2005-12-29 |
Pituitary adenylate cyclase activating peptide (PACAP)receptor 3 (R3) agonists and their pharmacological methods of use
Grant 6,972,319 - Pan , et al. December 6, 2 | 2005-12-06 |
VPAC1 selective antagonists and their pharmacological methods of use
App 20050203009 - Pan, Clark ; et al. | 2005-09-15 |
Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use
App 20050153890 - Pan, Clark ; et al. | 2005-07-14 |
Modified IL-4 mutein receptor antagonists
App 20050059590 - Pan, Clark ; et al. | 2005-03-17 |
Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use
Grant 6,864,069 - Pan , et al. March 8, 2 | 2005-03-08 |
Pituitary adenylate cyclase activating peptide (PACAP) receptor 3 (R3) agonists and their pharmacological methods of use
App 20050043237 - Pan, Clark ; et al. | 2005-02-24 |
Human TIMP-1 antibodies
App 20040105862 - Pan, Clark ; et al. | 2004-06-03 |
Pituitary adenylate cyclase activating peptide (PACAP) receptor (VPAC2) agonists and their pharmacological methods of use
App 20040058870 - Froland, Wayne A. ; et al. | 2004-03-25 |
Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use
App 20040002442 - Pan, Clark ; et al. | 2004-01-01 |
Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use
App 20030124669 - Pan, Clark ; et al. | 2003-07-03 |
| 